Stocks were looking for a higher open on Tuesday, with this day being a shortened one ahead of the July 4th holiday. The prior trend of buying the dips has not worked as well in recent months as it had in prior years. Many investors have been considering how they want their investments positioned ahead of the midterm elections and also for the longer term.
24/7 Wall St. reviews dozens of analyst research reports each day of the week. Our goal is to find new investing and trading ideas. Some analyst reports cover stocks to buy and some cover stocks to sell or to avoid.
Additional color and commentary have been added on most of the daily analyst reports. The consensus analyst price targets mentioned and other valuation metrics are from the Thomson Reuters sell-side research service.
These were the top analyst upgrades, downgrades and other research calls from Tuesday, July 3, 2018.
Albermarle Corp. (NYSE: ALB) was raised to Buy from Neutral with a $125 price target (versus a $93.48 prior close) at Goldman Sachs. It has a 52-week range of $86.75 to $144.99 and a consensus target price of $127.80.
Amazon.com Inc. (NASDAQ: AMZN) was reiterated as Buy and the price target was raised to $1,900 from $1,750 (versus a $1,713.78 close) at Argus. The independent research firm sees the fresh PillPack acquisition rattling drug stores and it raised its earnings estimate to $19.80 per share from $16.01 for 2019 (and 2018 to $12.93 from $12.63).
Amedisys Inc. (NASDAQ: AMED) was raised to Buy from Neutral with a $97 price objective (versus an $87.74 close) at Merrill Lynch.
American Airlines Group Inc. (NASDAQ: AAL) was downgraded to Hold from Buy with a $43 price target (versus a $38.36 close) at Deutsche Bank.
AmerisourceBergen Corp. (NYSE: ABC) was maintained as Equal Weight but the price target was cut to $88 from $97 at Morgan Stanley.
Autoliv Inc. (NYSE: ALV) was raised to Neutral from Sell with a $107 price target (versus a $101.74 close) at UBS.
Cardinal Health Inc. (NYSE: CAH) was maintained as Underweight but the price target was cut to $40 from $55 at Morgan Stanley.
Chevron Corp. (NYSE: CVX) was downgraded to Neutral from Outperform and the price target was cut to $125 from $140 at Macquarie. Chevron closed down 1.7% at $125.25 on Monday, and it has a 52-week range of $102.55 to $133.88. The consensus target price is up at $146.18.
CVS Health Corp. (NYSE: CVS) was maintained as Overweight but the price target was cut to $80 from $88 at Morgan Stanley.
Delta Air Lines Inc. (NYSE: DAL) was downgraded to Hold from Buy with a $53 price target (versus a $49.92 close) at Deutsche Bank.
Eloxx Pharmaceuticals Inc. (NASDAQ: ELOX) was started with a Buy rating and assigned a $31 price target (versus a $16.56 close, after a 3% drop) at Citigroup. The 52-week range is $3.60 to $24.60, and the consensus target price is $23.33.
Epizyme Inc. (NASDAQ: EPZM) was downgraded to Market Perform from Outperform and the price target was cut to $16 from $24 (versus a $13.60 close) at Leerink.
Follow @Jonogg on Twitter to receive the daily analyst calls and other market research calls directly on your feed.
Sponsored: Find a Qualified Financial Advisor
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.